Suboptimal response to combination therapy with tixagevimab/cilgavimab and remdesivir for persistent SARS-CoV-2 infections in immunocompromised patients-authors' response.

Saved in:
Bibliographic Details
Title: Suboptimal response to combination therapy with tixagevimab/cilgavimab and remdesivir for persistent SARS-CoV-2 infections in immunocompromised patients-authors' response.
Authors: Wu TY; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Chen PY; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan., Wang JT; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; National Institutes of Infectious Diseases and Vaccinology, National Health Research Institutes, Zhunan, Taiwan., Liu WD; Department of Internal Medicine, National Taiwan University Cancer Center, Taipei, Taiwan., Chen YC; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; National Institutes of Infectious Diseases and Vaccinology, National Health Research Institutes, Zhunan, Taiwan.; School of Medicine, National Taiwan University College of Medicine, Taipei, Taiwan., Chang SC; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; School of Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Source: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2024 Dec 02; Vol. 79 (12), pp. 3360-3361.
Publication Type: Editorial; Comment
Language: English
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN: 1460-2091 (Electronic) Linking ISSN: 03057453 NLM ISO Abbreviation: J Antimicrob Chemother Subsets: In Process; MEDLINE
Imprint Name(s): Publication: 1997- : London : Oxford University Press
Original Publication: London, New York, Academic Press.
Comments: Comment on: J Antimicrob Chemother. 2024 Sep 3;79(9):2400-2402. doi: 10.1093/jac/dkae234.. (PMID: 39073825)
Grant Information: 111-2321-B-002-017 Ministry of Science and Technology, Taiwan; 112-2321-B-002-013 National Science and Technology Council, Taiwan
Entry Date(s): Date Created: 20241007 Latest Revision: 20250514
Update Code: 20250514
DOI: 10.1093/jac/dkae357
PMID: 39373636
Database: MEDLINE
Description
ISSN:1460-2091
DOI:10.1093/jac/dkae357